Get the Stockscreener App
76.32
5.82%
4.20
Pre-market:
76.66
0.34
+0.45%
Transmedics Group Inc stock is traded at $76.32, with a volume of 2.78M.
It is up +5.82% in the last 24 hours and up +12.98% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$72.12
Open:
$73.66
24h Volume:
2.78M
Relative Volume:
1.43
Market Cap:
$2.56B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
81.19
EPS:
0.94
Net Cash Flow:
$-120.51M
1W Performance:
+6.07%
1M Performance:
+12.98%
6M Performance:
-54.59%
1Y Performance:
-6.47%
1-Day Range:
$73.00
$80.22
1-Week Range:
$71.51
$80.22
52-Week Range:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
76.32 | 2.56B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
138.01 | 239.35B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.79 | 153.17B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
386.19 | 147.36B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.02 | 118.00B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.62 | 42.24B | 5.72B | 4.17B | 490.10M | 6.97 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
(TMDX) Trading Report - Stock Traders Daily
TMDX REMINDER: TransMedics Group, Inc. was Sued for Securities Fraud; Investors are Alerted to Contact BFA Law before April 15 Deadline (NASDAQ:TMDX) - GlobeNewswire Inc.
Shareholders that lost money on TransMedics Group, Inc.(TMDX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire
TransMedics Group, Inc. (NASDAQ:TMDX) Position Increased by IFP Advisors Inc - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Purchased by Oppenheimer & Co. Inc. - MarketBeat
Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. Investors with Losses to Contact the Firm - PR Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmTMDX - Markets Insider
ROSEN, THE FIRST FILING FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel - The Bakersfield Californian
ROSEN, THE FIRST FILING FIRM, Encourages TransMedics Group, - GlobeNewswire
Are Investors Undervaluing TransMedics Group, Inc. (NASDAQ:TMDX) By 40%? - Yahoo Finance
New York State Common Retirement Fund Sells 28,440 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
New York State Common Retirement Fund Decreases Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
State of New Jersey Common Pension Fund D Buys 12,387 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your RightsTMDX - ACCESS Newswire
TransMedics Group (TMDX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
TMDX STOCK ALERT: A Class Action has been filed on behalf - GlobeNewswire
TransMedics Group (NASDAQ:TMDX) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
TransMedics Group (NASDAQ:TMDX) Releases Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your RightsTMDX - ACCESS Newswire
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman - GlobeNewswire
Transmedics Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Is TransMedics Group, Inc. (TMDX) the Worst Performing Mid Cap Stock to Buy According to Analysts? - Insider Monkey
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group - TradingView
TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2024 Earnings Call Transcript - Insider Monkey
TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates - Nasdaq
Lowey Dannenberg Notifies TransMedics Group, Inc. - GlobeNewswire
Is the Market Bullish or Bearish on TransMedics Gr? - Benzinga
TransMedics Group Inc (TMDX): A Strategic SWOT Insight - GuruFocus.com
TMDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
TransMedics Group, Inc. (NASDAQ:TMDX) Holdings Lifted by Rhumbline Advisers - Defense World
TransMedics revenue increases 50% to USD 121.6M in Q4 2024 - Medical Buyer
Principal Financial Group Inc. Sells 9,340 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Atria Wealth Solutions Inc. Sells 1,900 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Group, Inc. (TMDX) Investors: April 15, 2025 - GlobeNewswire
TransMedics Group Inc (TMDX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
TransMedics Group: A Landmark Year of Growth, Profitability, and Strategic Expansion in 2024 - HPBL
TransMedics Reports Strong Revenue Growth in 2024 - TipRanks
TransMedics: Q4 Earnings Snapshot - New Haven Register
TransMedics Group, Inc. to Host Earnings Call - ACCESS Newswire
Earnings call transcript: TransMedics Q4 2024 earnings beat expectations - Investing.com
TransMedics (TMDX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
TransMedics' Revenue Surged 49.8% in Q4 - Nasdaq
TransMedics Group Q4 Net Income, Revenue Rise; Shares Gain After Hours -February 27, 2025 at 05:33 pm EST - Marketscreener.com
TransMedics (TMDX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - Morningstar
TransMedics Group, Inc. SEC 10-K Report - TradingView
TransMedics Group stock surges on earnings beat and strong guidance By Investing.com - Investing.com Australia
TransMedics Group stock surges on earnings beat and strong guidance - Investing.com
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):